FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1946326335> ?p ?o ?g. }

• W1946326335 endingPage "4499" @default.
• W1946326335 startingPage "4495" @default.
• W1946326335 abstract "The polysaccharide capsule of Klebsiella pneumoniae is an important virulence factor that confers resistance to phagocytosis. The treatment of encapsulated bacteria with salicylate to inhibit capsule expression was found to enhance the phagocytosis of encapsulated bacteria by human neutrophils only in the presence of cell surface-specific antibodies. Both type-specific rabbit antisera and anticapsular human hyperimmune globulin were employed as opsonins. Salicylate significantly enhanced phagocytosis with homologous, but not heterologous, whole-cell antisera. Antisera, diluted 1:40, no longer opsonized fully encapsulated bacteria but promoted the uptake of multiple salicylate-treated bacteria in > 90% of neutrophils. Salicylate (0.25 to 1.0 mM) also enhanced opsonization with globulin against homologous bacteria. Higher salicylate levels (1 to 2.5 mM) enhanced the opsonization of heterologous serotypes with human globulin. The nature of antibody attachment to encapsulated bacteria was determined by immunofluorescence. Even after the addition of purified capsular polysaccharide to prevent phagocytosis, K-specific antibodies attached in large amounts to bacteria. K-specific antibodies reacted with antigens throughout the capsule and showed a predilection for a denser inner layer of the capsule, indicating that many of the K-specific antibodies may be masked underneath the capsule surface. K-specific antibodies can also be rendered nonfunctional by soluble, cell-free capsular antigen. In culture, large quantities of soluble capsular polysaccharide extrude from bacteria after overnight growth. The reduction in capsule expression caused by salicylate largely affected the soluble, cell-free fraction. Purified capsular polysaccharide was shown to retard the opsonophagocytosis of salicylate-treated bacteria in a concentration-dependent manner. However, extensive washing of encapsulated bacteria to remove loosely attached capsular material did not significantly enhance opsonophagocytosis. In conclusion, cell-free capsule and cell-associated capsule are antiphagocytic; both act to neutralize K-specific antibodies by binding or concealment. Salicylate-mediated inhibition of capsule expression, particularly of the cell-free fraction, improved K-specific opsonization dramatically." @default.
• W1946326335 created "2016-06-24" @default.
• W1946326335 creator A5003385022 @default.
• W1946326335 creator A5016031246 @default.
• W1946326335 creator A5073305158 @default.
• W1946326335 creator A5074683000 @default.
• W1946326335 date "1994-10-01" @default.
• W1946326335 modified "2023-10-11" @default.
• W1946326335 title "Polysaccharide capsule-mediated resistance to opsonophagocytosis in Klebsiella pneumoniae" @default.
• W1946326335 cites W111682225 @default.
• W1946326335 cites W1565712096 @default.
• W1946326335 cites W1775749144 @default.
• W1946326335 cites W1792036402 @default.
• W1946326335 cites W1819875891 @default.
• W1946326335 cites W1871859981 @default.
• W1946326335 cites W1902275581 @default.
• W1946326335 cites W1924294726 @default.
• W1946326335 cites W1932547257 @default.
• W1946326335 cites W1965028224 @default.
• W1946326335 cites W1976882955 @default.
• W1946326335 cites W2038185742 @default.
• W1946326335 cites W2072029917 @default.
• W1946326335 cites W2092416698 @default.
• W1946326335 cites W2092487369 @default.
• W1946326335 cites W2097586470 @default.
• W1946326335 cites W2111357759 @default.
• W1946326335 cites W2112229020 @default.
• W1946326335 cites W2118226712 @default.
• W1946326335 cites W2124459968 @default.
• W1946326335 cites W2401157216 @default.
• W1946326335 cites W2406513379 @default.
• W1946326335 cites W2440077656 @default.
• W1946326335 cites W2563782738 @default.
• W1946326335 cites W7170316 @default.
• W1946326335 doi "https://doi.org/10.1128/iai.62.10.4495-4499.1994" @default.
• W1946326335 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/303135" @default.
• W1946326335 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7927714" @default.
• W1946326335 hasPublicationYear "1994" @default.
• W1946326335 type Work @default.
• W1946326335 sameAs 1946326335 @default.
• W1946326335 citedByCount "108" @default.
• W1946326335 countsByYear W19463263352012 @default.
• W1946326335 countsByYear W19463263352013 @default.
• W1946326335 countsByYear W19463263352014 @default.
• W1946326335 countsByYear W19463263352015 @default.
• W1946326335 countsByYear W19463263352016 @default.
• W1946326335 countsByYear W19463263352017 @default.
• W1946326335 countsByYear W19463263352018 @default.
• W1946326335 countsByYear W19463263352019 @default.
• W1946326335 countsByYear W19463263352020 @default.
• W1946326335 countsByYear W19463263352021 @default.
• W1946326335 countsByYear W19463263352022 @default.
• W1946326335 countsByYear W19463263352023 @default.
• W1946326335 crossrefType "journal-article" @default.
• W1946326335 hasAuthorship W1946326335A5003385022 @default.
• W1946326335 hasAuthorship W1946326335A5016031246 @default.
• W1946326335 hasAuthorship W1946326335A5073305158 @default.
• W1946326335 hasAuthorship W1946326335A5074683000 @default.
• W1946326335 hasBestOaLocation W19463263351 @default.
• W1946326335 hasConcept C104317684 @default.
• W1946326335 hasConcept C147483822 @default.
• W1946326335 hasConcept C155292618 @default.
• W1946326335 hasConcept C159654299 @default.
• W1946326335 hasConcept C160448771 @default.
• W1946326335 hasConcept C168507396 @default.
• W1946326335 hasConcept C19655278 @default.
• W1946326335 hasConcept C203014093 @default.
• W1946326335 hasConcept C2780115692 @default.
• W1946326335 hasConcept C523546767 @default.
• W1946326335 hasConcept C54355233 @default.
• W1946326335 hasConcept C55493867 @default.
• W1946326335 hasConcept C60987743 @default.
• W1946326335 hasConcept C86803240 @default.
• W1946326335 hasConcept C89372155 @default.
• W1946326335 hasConcept C89423630 @default.
• W1946326335 hasConcept C91523082 @default.
• W1946326335 hasConceptScore W1946326335C104317684 @default.
• W1946326335 hasConceptScore W1946326335C147483822 @default.
• W1946326335 hasConceptScore W1946326335C155292618 @default.
• W1946326335 hasConceptScore W1946326335C159654299 @default.
• W1946326335 hasConceptScore W1946326335C160448771 @default.
• W1946326335 hasConceptScore W1946326335C168507396 @default.
• W1946326335 hasConceptScore W1946326335C19655278 @default.
• W1946326335 hasConceptScore W1946326335C203014093 @default.
• W1946326335 hasConceptScore W1946326335C2780115692 @default.
• W1946326335 hasConceptScore W1946326335C523546767 @default.
• W1946326335 hasConceptScore W1946326335C54355233 @default.
• W1946326335 hasConceptScore W1946326335C55493867 @default.
• W1946326335 hasConceptScore W1946326335C60987743 @default.
• W1946326335 hasConceptScore W1946326335C86803240 @default.
• W1946326335 hasConceptScore W1946326335C89372155 @default.
• W1946326335 hasConceptScore W1946326335C89423630 @default.
• W1946326335 hasConceptScore W1946326335C91523082 @default.
• W1946326335 hasIssue "10" @default.
• W1946326335 hasLocation W19463263351 @default.
• W1946326335 hasLocation W19463263352 @default.
• W1946326335 hasOpenAccess W1946326335 @default.
• W1946326335 hasPrimaryLocation W19463263351 @default.

• next